Bigfoot Biomedical touted data last week at this year’s Diabetes Technology Meeting showing that results from a feasibility study evaluating the company’s automated insulin delivery system closely matched data gleaned from prospective modeling.
The company said it conducted extensive modeling to refine the technology’s algorithms prior to the start of its trial in 2016, Bigfoot said. Data collected from simulations closely predicted how Bigfoot’s automated insulin delivery system would perform when tested in a group of diverse patients.
Get the full story at our sister site, Drug Delivery Business News.
The post Bigfoot compares trial data with modeling results for automated insulin delivery system appeared first on MassDevice.